Inovio Pharmaceuticals INO Balance Sheet

Income Statement

Quarter End	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	495.94M	445.51M	459.4M	391.97M	348.53M	266.58M	233.04M	193.1M
Total Current Assets	448.45M	399.91M	416.19M	350.21M	315.24M	233.9M	203.29M	174.77M
Cash and Equivalents	71.14M	59.01M	41.1M	21.99M	46.33M	28.24M	52.71M	18.81M
Total Non-Current Assets	64.95M	45.6M	43.21M	41.76M	41.02M	32.69M	29.75M	18.33M
Total Liabilities	96.27M	90.43M	161.73M	125.27M	126.17M	67.37M	63.67M	54.94M
Total Current Liabilities	65.74M	59.36M	131.06M	94.92M	96.87M	55.15M	51.93M	43.71M
Total Non-Current Liabilities	45.49M	47.27M	47.19M	46.66M	45.92M	12.22M	11.73M	11.23M
Common Equity	217k	226k	248k	249k	253k	263k	268k	270k
Retained Earnings	-1.21B	-1.29B	-1.4B	-1.43B	-1.49B	-1.53B	-1.56B	-1.6B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	173.71M	187.24M	131.11M	143.95M	539.77M	495.94M	348.53M	170.95M
Total Current Assets	124.6M	138.36M	87.82M	94.2M	471.17M	448.45M	315.24M	153.11M
Cash and Equivalents	19.14M	23.79M	23.69M	22.2M	250.73M	71.14M	46.33M	14.31M
Total Non-Current Assets	123.38M	142.49M	87.03M	5.41M	461.14M	399.67M	222.36M	117.35M
Total Liabilities	50.33M	44.75M	44.08M	138.55M	78.63M	96.27M	126.17M	53.6M
Total Current Liabilities	43.82M	35.41M	35.3M	31.99M	41.71M	65.74M	96.87M	42.57M
Total Non-Current Liabilities	6.51M	9.35M	8.78M	183.58M	55.58M	45.49M	45.92M	11.03M
Total Equity	123.38M	142.49M	87.03M	5.41M	461.14M	399.67M	222.36M	117.35M
Common Equity	74k	90k	97k	101k	187k	217k	253k	23k
Retained Earnings	-434.84M	-523.36M	-620.43M	-739.79M	-906.2M	-1.21B	-1.49B	-1.62B